|
|
|
Insider
Information: |
Lindop Christopher J |
Relationship: |
EVP |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
435,329 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,446,697 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
435,329 |
|
|
Total
Value |
$5,446,697 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PAREXEL International |
PRXL |
Director |
2017-09-29 |
0 |
2006-11-01 |
0 |
Premium* |
|
Haemonetics Corp |
HAE |
CFO & EVP Business Dev... |
2016-01-13 |
56,743 |
2007-10-24 |
0 |
Premium* |
|
Alere Inc |
ALR |
Chief Financial Officer |
2005-12-31 |
1,939 |
2005-06-30 |
0 |
Premium* |
|
Quotient Ltd |
QTNTQ |
EVP |
2020-05-24 |
376,647 |
2017-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRXL |
PAREXEL International |
Director |
|
2011-09-19 |
4 |
AS |
$20.98 |
$52,450 |
D/D |
(2,500) |
44,743 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2013-02-12 |
4 |
S |
$34.40 |
$87,479 |
D/D |
(2,543) |
37,211 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2013-10-28 |
4 |
D |
$39.55 |
$103,190 |
D/D |
(2,609) |
32,845 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2014-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,662 |
32,255 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & Vice President of |
|
2011-10-25 |
4 |
A |
$0.01 |
$27 |
D/D |
2,689 |
13,650 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2017-09-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,850 |
17,774 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & VP of B D |
|
2010-10-27 |
4 |
A |
$0.01 |
$29 |
D/D |
2,891 |
11,264 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & Vice President of |
|
2008-10-23 |
4 |
A |
$0.01 |
$31 |
D/D |
3,064 |
6,275 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2013-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,277 |
40,488 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2012-03-08 |
4 |
S |
$24.33 |
$97,320 |
D/D |
(4,000) |
48,155 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-03-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
42,493 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-03-20 |
4 |
AS |
$44.26 |
$216,983 |
D/D |
(4,902) |
37,591 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-04-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
42,735 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-04-20 |
4 |
AS |
$41.55 |
$203,676 |
D/D |
(4,902) |
37,833 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-05-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-05-20 |
4 |
AS |
$41.65 |
$204,172 |
D/D |
(4,902) |
38,188 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-06-22 |
4 |
AS |
$42.51 |
$208,394 |
D/D |
(4,902) |
38,188 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-06-22 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-07-20 |
4 |
AS |
$39.09 |
$191,610 |
D/D |
(4,902) |
38,188 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-07-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-08-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2015-08-20 |
4 |
AS |
$38.49 |
$188,688 |
D/D |
(4,902) |
38,188 |
0 |
- |
|
HAE |
Haemonetics Corp |
CFO & EVP Business Development |
|
2013-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,040 |
35,454 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2012-09-25 |
4 |
AS |
$30.92 |
$158,063 |
D/D |
(5,112) |
40,454 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2012-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,211 |
45,566 |
0 |
- |
|
105 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|